Aflofarm

Aflofarm is one of the largest and most recognizable pharmaceutical companies in Poland, operating in the health care sector for thirty years. Over this time, we have commercially released over 115 product brands. We are currently the leader of the OTC pharmaceuticals market with brands like Desmoxan, Neosine and Dafurag.

Read more about us

No. 1
on the OTC market

We are one of the biggest Polish pharmaceuticals companies and the OTC market leader since 2012.

115+
product brands

We offer an extensive product portfolio, including prescription and OTC drugs, medical devices, cosmetics, and dietary supplements.

1000+
employees

Aflofarm's success comes mainly from our employees. Our staff includes pharmacists, physicians, biotechnologists, technologists, and marketers.

30
export countries

Our business heavily relies on export - our products are available in 30 countries throughout the world.

We have a comprehensive approach to patients

We take comprehensive care of patients and help out with their health, disposition, and fitness. We also offer beauty and personal hygiene products.

See our products

Quality is the priority

All our drugs and non-medicinal products are manufactured on technological lines guaranteeing top product quality in accordance with Good Manufacturing Practices.

Learn more about quality at Aflofarm

We take responsibility

Social responsibility is a priority in our everyday business practices. We have established the Aflofarm Foundation in order to promote health promotion and bring help to those in need. We also pay close attention to our community. For years we have been working for the benefit of Pabianice, the home of our company.

Learn more about social responsibility in Aflofarma

We are a Polish company with a global range

We export our products to 30 countries throughout the world, including Hungary, Czech Republic, Romania, Bulgaria, Turkey, United Kingdom, Vietnam, Greece, United States, post-Soviet countries like Georgia, Belarus, Ukraine, Turkmenistan, Azerbaijan, and Middle East countries like Iraq, UAE, and Kuwait.

Our drugs are made by people

I like how open Aflofarm's executives are to new, often unconventional ideas, which is why we are able to release new and innovative drugs.

Małgorzata, Senior Liquid Forms Technologist

In Aflofarm you can count on everyone, regardless of position. Therefore, people are the most important value of this company.

Maciek, Brand Manager

The new drug is hundreds of hours of quality control, laboratory and production testing. But knowing that we are helping someone makes it impossible for me to replace this work with any other.

Magda, Validation Specialist

1000+
employees

Aflofarm is composed of professionals in various fields, who work in our laboratories, offices, factories, and in the field.

join us

News

Can a horse advertise erection drugs? Aflofarm's new campaign proves that it surely can! The first of a series of commercial spots for the erection medicine Inventum Max premiered on 20th June. The campaign takes a tongue-in-cheek approach towards erectile dysfunction, which is a common problem among men.

read more

Aflofarm Farmacja Polska was awarded the Diamond of Innovation award in the category "Innovation of the Year: Pharmacy". Jacek Furman, the President at Aflofarm, received the award during the official gala crowning the 9th edition of the Executive Innovation Forum. This constitutes another prestigious award for the company, which emphasizes the right direction for the development of the brand, and shows the recognition among external entities for the activities of the Pabianice-based company.

read more

Exhaustion, long-term stress, nervousness, but also an increase in alcohol consumption and cigarette smoking and - above all - deterioration of health and difficulty in contacting a physician - this is the image that emerges from the nationwide report "Poles one year after the SARS-CoV-2 pandemic outbreak", published by Aflofarm Foundation. What other effects has one year of fighting the pandemic brought?

read more
This site uses cookies for services in accordance with the Privacy Policy